Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease
NCT ID: NCT05150197
Last Updated: 2025-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1000 participants
INTERVENTIONAL
2022-01-19
2026-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will recruit both healthy children, as well children and young adults who have eye conditions which require visual field testing as part of their standard care. The test will be performed on a day when the child or young adult already has a scheduled eye appointment as standard care. The test does not touch the eyes or require any eye drops to be given, and there is no known risk associated with the test itself. There may be a risk of loss of confidentiality. Participating in this study will require approximately 30 minutes, has no extra cost associated with it, and will be compensated by a parking pass for the day of the visit. There are no direct benefits for participants.
Selected participants will be also be given training and then loaned a home VisuALL system to allow home visual field testing. If your child is selected, additional information would be provided.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establishing a Normative Database in Pediatric Population of the Head-mounted visuALL Field Analyzer
NCT04175444
A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics
NCT02157025
Cell Phone Application for Vision Assessment
NCT03212222
Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking
NCT05141604
Determining the Clinical Utility of Using Virtual Reality Headsets to Assess Visual Function in Those With Glaucoma.
NCT04273438
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient (pathology) group
This group will perform both the standard of care Humphrey Visual Field (HVF) and the VisuALL Virtual Reality Visual Field.
VisuALL
Virtual Reality Visual Field Device
Humphrey Visual Field
Standard of care Visual Field test
Control group
This group will only perform the VisuALL Virtual Reality Visual Field.
VisuALL
Virtual Reality Visual Field Device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VisuALL
Virtual Reality Visual Field Device
Humphrey Visual Field
Standard of care Visual Field test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cognitively normal (no developmental delay or syndrome)
* Be able to tolerate wearing the virtual reality goggles for at least 10 minutes
* Be able to provide informed consent of a parent/guardian (and assent if 12 years or older)
* Do not have any ocular diseases that could interfere with the visual field testing
Exclusion Criteria
* Inability to obtain consent
* Inability to understand English
4 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharon F Freedman, MD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Razeghinejad R, Gonzalez-Garcia A, Myers JS, Katz LJ. Preliminary Report on a Novel Virtual Reality Perimeter Compared With Standard Automated Perimetry. J Glaucoma. 2021 Jan 1;30(1):17-23. doi: 10.1097/IJG.0000000000001670.
Montelongo M, Gonzalez A, Morgenstern F, Donahue SP, Groth SL. A Virtual Reality-Based Automated Perimeter, Device, and Pilot Study. Transl Vis Sci Technol. 2021 Mar 1;10(3):20. doi: 10.1167/tvst.10.3.20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00109426
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.